Paul Grant Higham
Vorstandsvorsitzender bei Valo Therapeutics Ltd.
Ursprung des Netzwerks ersten Grades von Paul Grant Higham
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
35
| Public Company | Pharmaceuticals: Major | 35 |
Glaxo Wellcome Plc
18
| Extinct | Pharmaceuticals: Major | 18 |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Valo Therapeutics Oy
 Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Glycotope GmbH
 Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany.
1
| Subsidiary | Biotechnology | 1 |
Valo Therapeutics Ltd.
1
| Subsidiary | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Paul Grant Higham
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Director of Finance/CFO Director of Finance/CFO Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Chairman Founder Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Oxford | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| COVESTRO AG | Chemicals: Specialty | Chairman Director/Board Member Corporate Officer/Principal | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman Director/Board Member | |
| University of London | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| IMMATICS N.V. | Biotechnology | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
LANXESS India Pvt Ltd.
 LANXESS India Pvt Ltd. Chemicals: SpecialtyProcess Industries LANXESS India Pvt Ltd. manufactures, develops and distributes specialty chemicals, plastics, rubber and intermediates. The firm's products include poly-butadiene rubber, butyl rubber, engineering plastics, chemical intermediates and performance chemicals. The firm provides services to agriculture, automotive, construction, water treatment, leather and plastics markets. The company was founded in February 20, 2004 and is headquartered in Thane, India. | Chemicals: Specialty | Chairman Director/Board Member Corporate Officer/Principal | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Verband der Chemischen Industrie eV
 Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Covestro Deutschland AG
 Covestro Deutschland AG Chemicals: SpecialtyProcess Industries Covestro Deutschland AG engages in the production and distribution of polymers. It also sells paints and adhesive raw materials. The company was founded on April 8, 2002 and is headquartered in Leverkusen, Germany. | Chemicals: Specialty | Chairman Director/Board Member Corporate Officer/Principal | |
| RWTH Aachen University | College/University | Undergraduate Degree Doctorate Degree | |
Bayer SA (Brazil)
 Bayer SA (Brazil) Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Bayer SA (Brazil) is a Brazilian company that manufactures and sells pharmaceuticals and fertilizers. The company is based in São Paulo, Brazil. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Cancer Research UK
 Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Münster | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Reading | College/University | Undergraduate Degree Undergraduate Degree | |
| Universität zu Köln | College/University | Undergraduate Degree Doctorate Degree | |
Oxstem Ltd.
 Oxstem Ltd. BiotechnologyHealth Technology Oxstem Ltd. develops cell programming therapies. The company is headquartered in Oxford, the United Kingdom. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| University of Bristol | College/University | Undergraduate Degree Doctorate Degree | |
Bayer Business Services GmbH
 Bayer Business Services GmbH Miscellaneous Commercial ServicesCommercial Services Bayer Business Services GmbH is a business process outsourcing company. It offers services in the fields of information technology, infrastructure, purchasing & logistics, human resources, and management administration. The company was founded in 2002 and is headquartered in Leverkusen, Germany. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Freedom Innovations LLC
 Freedom Innovations LLC Medical SpecialtiesHealth Technology Freedom Innovations LLC designs, manufactures, and markets prosthetic devices. The firm focuses on developing lower limb prosthetic solutions in collaboration with prosthetists and amputees. Its products include Renegade, Thrive, Pacifica, DynAdapt, Agilix, and Maverick Comfort AT. The company was founded in 2002 and is headquartered in Irvine, CA. | Medical Specialties | President Director/Board Member | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Chief Tech/Sci/R&D Officer Director/Board Member | |
| Bayer Pharmaceuticals Corp. | Director of Finance/CFO President | ||
| Asian Institute of Management | College/University | Masters Business Admin Masters Business Admin | |
| LANXESS AG | Chemicals: Major Diversified | Chairman President | |
GeneOhm Sciences, Inc.
 GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Medical Specialties | Chairman Director of Finance/CFO | |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
| Imperial College London | College/University | Corporate Officer/Principal Doctorate Degree | |
| BAYER CROPSCIENCE LIMITED | Chemicals: Agricultural | Chief Executive Officer Chief Executive Officer | |
| University of Helsinki | College/University | Corporate Officer/Principal Graduate Degree | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
| MERCK KGAA | Pharmaceuticals: Major | Chairman Director/Board Member | |
| EPIGENOMICS AG | Medical Specialties | Chairman Chairman | |
| PAION AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Digital Broadcasting Corporation Hong Kong Ltd.
 Digital Broadcasting Corporation Hong Kong Ltd. BroadcastingConsumer Services Digital Broadcasting Corporation Hong Kong Ltd. provides digital audio broadcasting services. The private company is based in Hong Kong, Hong Kong. The Chinese company was founded by Jing-Han Cheng. | Broadcasting | Chairman | |
| University of Hamburg | College/University | Undergraduate Degree | |
| The Chinese University of Hong Kong | College/University | Corporate Officer/Principal | |
| The University of Southampton | College/University | Doctorate Degree | |
| CAIXABANK, S.A. | Regional Banks | Director/Board Member |
Statistik
International
| Deutschland | 19 |
| Vereinigtes Königreich | 14 |
| Vereinigte Staaten | 10 |
| Indien | 3 |
| Hong Kong | 3 |
Sektoral
| Health Technology | 22 |
| Consumer Services | 18 |
| Process Industries | 6 |
| Commercial Services | 6 |
| Finance | 2 |
Operativ
| Director/Board Member | 339 |
| Corporate Officer/Principal | 199 |
| Chairman | 123 |
| Chief Executive Officer | 108 |
| President | 65 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Richard Sykes | 37 |
| J. Kenneth Charles Knowles | 29 |
| David Lawrence | 29 |
| Tim Tyson | 28 |
| Rainier van Roessel | 26 |
| Stuart J. M. Collinson | 25 |
| Clive Dix | 24 |
| Peter Chambré | 23 |
| Katina Dorton | 22 |
| Anthony Giovinazzo | 22 |
| Kwok Cheung Li | 21 |
| Trevor Phillips | 20 |
| Heino von Prondzynski | 19 |
| Peter Vanacker | 17 |
| Harald F. Stock | 17 |
- Börse
- Insiders
- Paul Grant Higham
- Unternehmensverbindungen
